Medical Innovation Exchange

cell therapy

FDA Approves Second Indication for Casgevy Cell-based Gene Therapy

FDA Approves Second Indication for Casgevy Cell-based Gene Therapy     On January 16, the FDA approved Casgevy from Vertex, a cell-based gene therapy, for the treatment of patients 12 years of age and older with transfusion-dependent beta-thalassemia (TDT), an inherited disorder characterized by life-long anemia requiring frequent blood transfusions. To produce Casgevy, patients’ hematopoietic (blood) …

FDA Approves Second Indication for Casgevy Cell-based Gene Therapy Read More »

Device Development: A Hybrid Implantable Kidney

Device Development: A Hybrid Implantable Kidney     Shuvo Roy, Ph.D., Professor of Bioengineering at UCSF and Technical Director of The Kidney Project, and his research partners have developed an artificial kidney constructed of semiconductor silicon wafers that remove waste and toxins from the blood and a cell therapy unit that replicates other kidney functions. Their …

Device Development: A Hybrid Implantable Kidney Read More »